DNAJC7 and amyotrophic lateral sclerosis: ALS-associated mutations may inhibit DnaJC7 interaction with other chaperones (e.g. Hsp70 and Hsp90) and thus impair substrate (tau) handoff into the chaperone-mediated protein refolding cycle.